Phosphoribosyl Pyrophosphate Amido Transferase: A New Prognostic Biomarker for Hepatocellular Carcinoma.

Qingfei ChuXinyu GuQiuxian ZhengJing WangHaihong Zhu

Published in: International journal of general medicine (2022)

Our study demonstrated that PPAT expression might be included in the process of carcinogenesis and prognosis. Hence, PPAT could be served as a new prognostic biomarker for patients of HCC.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
poor prognosis
patient reported outcomes
long non coding rna
patient reported